• Report SKU:SKU: SYNR10018
  • Description
  • Table of Contents
  • Request Sample

The Global Autoimmune Drugs market is expected to reach $38.15 billion by 2027 growing at a CAGR of 7.8% from 2020 to 2027. An autoimmune disease is a condition in which the immune system mistakenly attacks and damages its own tissues. Treatment for autoimmune diseases generally centered on reducing immune system activity. Autoimmune diseases are more commonly caused by genetic, infectious, or environmental factors. Factors such as the introduction of affordable biosimilars and the strong R&D pipeline are driving market growth. However, the expensive nature of biologics used in the treatment of autoimmune disorders is restraining the market growth. Based on the drug class, the non-steroidal anti-inflammatory drugs (NSAIDs) segment is going to have a lucrative growth during the forecast period owing to ease in availability, a huge target population, and access to advanced drugs. These anti-inflammatory medications relieve some lupus symptoms by reducing the inflammation responsible for the stiffness and discomfort in your muscle, joints, and other tissues. The key vendors mentioned are Amgen Inc., Zydus Cadila , Sanofi SA, Pfizer Inc., AbbVie Inc., Johnson and Johnson Inc., GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Bristol-Myers Squibb Co., Autoimmune Technologies, Novartis AG and Abbott Laboratories. Product Types Covered: • T Cell Inhibitors • Interleukin Inhibitors • Beta Interferons • Immunosuppressants • B Cell Inhibitors • Insulin Disease Types Covered: • Sjogren Syndrome • Vitiligo • Type 1 Diabetes • Systemic Lupus Erythematosus (SLE) • Pernicious Anemia • Rheumatoid Arthritis (RA) • Psoriasis • Multiple Sclerosis (MS) • Inflammatory Bowel Disease (IBD) • Hashimotos Thyroidtis • Graves Disease • Ankylosing Spondylitis (AS) Drug Classes Covered: • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) • Disease-Modifying Antirheumatic Drugs (DMARDs) • Corticosteroids • Analgesics Mechanism of Actions Covered: • Tumor Necrosis Factor (TNF) Inhibitors • Cyclooxygenase (COX) Inhibitors • Phosphodiestrase Type 4 Inhibitors Applications Covered: • Clinical Laboratories • Hospital • Homecare Settings Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2019 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analyzed during the forecast period

1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Autoimmune Drugs Market, By Product Type
5.1 Introduction
5.2 T Cell Inhibitors
5.3 Interleukin Inhibitors
5.4 Beta Interferons
5.5 Immunosuppressants
5.6 B Cell Inhibitors
5.7 Insulin

6 Global Autoimmune Drugs Market, By Disease Type
6.1 Introduction
6.2 Sjogren Syndrome
6.3 Vitiligo
6.4 Type 1 Diabetes
6.5 Systemic Lupus Erythematosus (SLE)
6.6 Pernicious Anemia
6.7 Rheumatoid Arthritis (RA)
6.8 Psoriasis
6.9 Multiple Sclerosis (MS)
6.10 Inflammatory Bowel Disease (IBD)
6.11 Hashimotos Thyroidtis
6.12 Graves Disease
6.13 Ankylosing Spondylitis (AS)

7 Global Autoimmune Drugs Market, By Drug Class
7.1 Introduction
7.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
7.3 Disease-Modifying Antirheumatic Drugs (DMARDs)
7.4 Corticosteroids
7.5 Analgesics

8 Global Autoimmune Drugs Market, By Mechanism of Action
8.1 Introduction
8.2 Tumor Necrosis Factor (TNF) Inhibitors
8.3 Cyclooxygenase (COX) Inhibitors
8.4 Phosphodiestrase Type 4 Inhibitors

9 Global Autoimmune Drugs Market, By Application
9.1 Introduction
9.2 Clinical Laboratories
9.3 Hospital
9.4 Homecare Settings

10 Global Autoimmune Drugs Market, By Geography
10.1 Introduction
10.2 North America
10.3 Europe
10.4 Asia Pacific
10.5 South America
10.6 Middle East & Africa

11 Strategic Benchmarking

12 Vendors Landscape
12.1 Amgen Inc.
12.2 Zydus Cadila
12.3 Sanofi SA
12.4 Pfizer Inc.
12.5 AbbVie Inc.
12.6 Johnson and Johnson Inc.
12.7 GlaxoSmithKline Plc
12.8 F. Hoffmann-La Roche Ltd.
12.9 Eli Lilly and Company
12.10 Bristol-Myers Squibb Co.
12.11 Autoimmune Technologies
12.12 Novartis AG
12.13 Abbott Laboratories

List of Data Tables
1 Global Autoimmune Drugs Market Outlook, By Region (2018-2026) ($MN)
2 Global Autoimmune Drugs Market Outlook, By Product Type (2018-2026) ($MN)
3 Global Autoimmune Drugs Market Outlook, By T Cell Inhibitors (2018-2026) ($MN)
4 Global Autoimmune Drugs Market Outlook, By Interleukin Inhibitors (2018-2026) ($MN)
5 Global Autoimmune Drugs Market Outlook, By Beta Interferons (2018-2026) ($MN)
6 Global Autoimmune Drugs Market Outlook, By Immunosuppressants (2018-2026) ($MN)
7 Global Autoimmune Drugs Market Outlook, By B Cell Inhibitors (2018-2026) ($MN)
8 Global Autoimmune Drugs Market Outlook, By Insulin (2018-2026) ($MN)
9 Global Autoimmune Drugs Market Outlook, By Disease Type (2018-2026) ($MN)
10 Global Autoimmune Drugs Market Outlook, By Sjogren Syndrome (2018-2026) ($MN)
11 Global Autoimmune Drugs Market Outlook, By Vitiligo (2018-2026) ($MN)
12 Global Autoimmune Drugs Market Outlook, By Type 1 Diabetes (2018-2026) ($MN)
13 Global Autoimmune Drugs Market Outlook, By Systemic Lupus Erythematosus (SLE) (2018-2026) ($MN)
14 Global Autoimmune Drugs Market Outlook, By Pernicious Anemia (2018-2026) ($MN)
15 Global Autoimmune Drugs Market Outlook, By Rheumatoid Arthritis (RA) (2018-2026) ($MN)
16 Global Autoimmune Drugs Market Outlook, By Psoriasis (2018-2026) ($MN)
17 Global Autoimmune Drugs Market Outlook, By Multiple Sclerosis (MS) (2018-2026) ($MN)
18 Global Autoimmune Drugs Market Outlook, By Inflammatory Bowel Disease (IBD) (2018-2026) ($MN)
19 Global Autoimmune Drugs Market Outlook, By Hashimotos Thyroidtis (2018-2026) ($MN)
20 Global Autoimmune Drugs Market Outlook, By Graves Disease (2018-2026) ($MN)
21 Global Autoimmune Drugs Market Outlook, By Ankylosing Spondylitis (AS) (2018-2026) ($MN)
22 Global Autoimmune Drugs Market Outlook, By Drug Class (2018-2026) ($MN)
23 Global Autoimmune Drugs Market Outlook, By Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (2018-2026) ($MN)
24 Global Autoimmune Drugs Market Outlook, By Disease-Modifying Antirheumatic Drugs (DMARDs) (2018-2026) ($MN)
25 Global Autoimmune Drugs Market Outlook, By Corticosteroids (2018-2026) ($MN)
26 Global Autoimmune Drugs Market Outlook, By Analgesics (2018-2026) ($MN)
27 Global Autoimmune Drugs Market Outlook, By Mechanism of Action (2018-2026) ($MN)
28 Global Autoimmune Drugs Market Outlook, By Tumor Necrosis Factor (TNF) Inhibitors (2018-2026) ($MN)
29 Global Autoimmune Drugs Market Outlook, By Cyclooxygenase (COX) Inhibitors (2018-2026) ($MN)
30 Global Autoimmune Drugs Market Outlook, By Phosphodiestrase Type 4 Inhibitors (2018-2026) ($MN)
31 Global Autoimmune Drugs Market Outlook, By Application (2018-2026) ($MN)
32 Global Autoimmune Drugs Market Outlook, By Clinical Laboratories (2018-2026) ($MN)
33 Global Autoimmune Drugs Market Outlook, By Hospital (2018-2026) ($MN)
34 Global Autoimmune Drugs Market Outlook, By Homecare Settings (2018-2026) ($MN)
35 North America Autoimmune Drugs Market Outlook, By Product Type (2018-2026) ($MN)
36 North America Autoimmune Drugs Market Outlook, By Disease Type (2018-2026) ($MN)
37 North America Autoimmune Drugs Market Outlook, By Drug Class (2018-2026) ($MN)
38 North America Autoimmune Drugs Market Outlook, By Mechanism of Action (2018-2026) ($MN)
39 North America Autoimmune Drugs Market Outlook, By Application (2018-2026) ($MN)
40 Europe Autoimmune Drugs Market Outlook, By Product Type (2018-2026) ($MN)
41 Europe Autoimmune Drugs Market Outlook, By Disease Type (2018-2026) ($MN)
42 Europe Autoimmune Drugs Market Outlook, By Drug Class (2018-2026) ($MN)
43 Europe Autoimmune Drugs Market Outlook, By Mechanism of Action (2018-2026) ($MN)
44 Europe Autoimmune Drugs Market Outlook, By Application (2018-2026) ($MN)
45 Asia Pacific Autoimmune Drugs Market Outlook, By Product Type (2018-2026) ($MN)
46 Asia Pacific Autoimmune Drugs Market Outlook, By Disease Type (2018-2026) ($MN)
47 Asia Pacific Autoimmune Drugs Market Outlook, By Drug Class (2018-2026) ($MN)
48 Asia Pacific Autoimmune Drugs Market Outlook, By Mechanism of Action (2018-2026) ($MN)
49 Asia Pacific Autoimmune Drugs Market Outlook, By Application (2018-2026) ($MN)
50 South America Autoimmune Drugs Market Outlook, By Product Type (2018-2026) ($MN)
51 South America Autoimmune Drugs Market Outlook, By Disease Type (2018-2026) ($MN)
52 South America Autoimmune Drugs Market Outlook, By Drug Class (2018-2026) ($MN)
53 South America Autoimmune Drugs Market Outlook, By Mechanism of Action (2018-2026) ($MN)
54 South America Autoimmune Drugs Market Outlook, By Application (2018-2026) ($MN)
55 Middle East & Africa Autoimmune Drugs Market Outlook, By Product Type (2018-2026) ($MN)
56 Middle East & Africa Autoimmune Drugs Market Outlook, By Disease Type (2018-2026) ($MN)
57 Middle East & Africa Autoimmune Drugs Market Outlook, By Drug Class (2018-2026) ($MN)
58 Middle East & Africa Autoimmune Drugs Market Outlook, By Mechanism of Action (2018-2026) ($MN)
59 Middle East & Africa Autoimmune Drugs Market Outlook, By Application (2018-2026) ($MN)